PRC
GH icon

Pearl River Capital’s Guardant Health GH Stock Holding History

Pearl River Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,989
Closed -$405K – 393
2020
Q2 		$405K Buy
4,989
+4,689
+1,563% +$378K 0.2% 164
2020
Q1 		$21K Buy
+300
New +$23K 0.04% 321

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Pearl River Capital's GH Position: Q3 2020 in Review

Pearl River Capital sold out of Guardant Health (GH) in Q3 2020, closing a stake of 4,989 shares — an estimated $405K sold.

Pearl River Capital first reported a position in GH in Q1 2020 and held it in 2 quarters. The position peaked at $405K in Q2 2020. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

  • Pearl River Capital reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
  • Pearl River Capital sold 4,989 Guardant Health shares in Q3 2020, an estimated $405K.
  • Pearl River Capital first reported a position in Guardant Health in Q1 2020 and held it in 2 quarters.
  • Pearl River Capital's Guardant Health position peaked at $405K in Q2 2020.
  • 346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on Pearl River Capital's 13F filing for Q3 2020, filed 13 Nov 2020.